Recursion Pharmaceuticals News - September 21, 2026

🟢 Recursion Pharmaceuticals is trading 4% up today after Tempus committed $42 million in payments

Recursion Pharmaceuticals is trading at $3.98 (+4.05%) on September 21, 2026, after expanding its Tempus AI partnership and licensing its TxFM RNA sequencing...

Recursion Expands Tempus AI Partnership, Licenses AI Model for $12M Fee

Recursion Pharmaceuticals has entered into two agreements with Tempus AI, Inc., expanding their collaboration. The company amended its existing master data...